_version_ 1785090827279663104
author Frerichs, Kristine
Verkleij, Christie
Mateos, Maria-Victoria
Zweegman, Sonja
Groen, Kaz
Kuipers, Ilse
Martin, Tom
Rodriguez, Cesar
Nooka, Ajay
Kruijswijk, Sandy
Skerget, Sheri
Doyle, Margaret
Banerjee, Arnob
Chastain, Katherine
Perales-Puchalt, Alfredo
Stephenson, Tara
Uhlar, Clarissa
Kobos, Rachel
Verona, Raluca
van de Donk, Niels W.C.J.
author_facet Frerichs, Kristine
Verkleij, Christie
Mateos, Maria-Victoria
Zweegman, Sonja
Groen, Kaz
Kuipers, Ilse
Martin, Tom
Rodriguez, Cesar
Nooka, Ajay
Kruijswijk, Sandy
Skerget, Sheri
Doyle, Margaret
Banerjee, Arnob
Chastain, Katherine
Perales-Puchalt, Alfredo
Stephenson, Tara
Uhlar, Clarissa
Kobos, Rachel
Verona, Raluca
van de Donk, Niels W.C.J.
author_sort Frerichs, Kristine
collection PubMed
description
format Online
Article
Text
id pubmed-10429903
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104299032023-08-17 P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS Frerichs, Kristine Verkleij, Christie Mateos, Maria-Victoria Zweegman, Sonja Groen, Kaz Kuipers, Ilse Martin, Tom Rodriguez, Cesar Nooka, Ajay Kruijswijk, Sandy Skerget, Sheri Doyle, Margaret Banerjee, Arnob Chastain, Katherine Perales-Puchalt, Alfredo Stephenson, Tara Uhlar, Clarissa Kobos, Rachel Verona, Raluca van de Donk, Niels W.C.J. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429903/ http://dx.doi.org/10.1097/01.HS9.0000972904.51933.45 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Frerichs, Kristine
Verkleij, Christie
Mateos, Maria-Victoria
Zweegman, Sonja
Groen, Kaz
Kuipers, Ilse
Martin, Tom
Rodriguez, Cesar
Nooka, Ajay
Kruijswijk, Sandy
Skerget, Sheri
Doyle, Margaret
Banerjee, Arnob
Chastain, Katherine
Perales-Puchalt, Alfredo
Stephenson, Tara
Uhlar, Clarissa
Kobos, Rachel
Verona, Raluca
van de Donk, Niels W.C.J.
P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS
title P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS
title_full P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS
title_fullStr P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS
title_full_unstemmed P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS
title_short P1506: TECLISTAMAB REDUCES POLYCLONAL IMMUNOGLOBULIN LEVELS AND IMPAIRS VACCINATION RESPONSES IN HEAVILY PRETREATED MM PATIENTS
title_sort p1506: teclistamab reduces polyclonal immunoglobulin levels and impairs vaccination responses in heavily pretreated mm patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429903/
http://dx.doi.org/10.1097/01.HS9.0000972904.51933.45
work_keys_str_mv AT frerichskristine p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT verkleijchristie p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT mateosmariavictoria p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT zweegmansonja p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT groenkaz p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT kuipersilse p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT martintom p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT rodriguezcesar p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT nookaajay p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT kruijswijksandy p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT skergetsheri p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT doylemargaret p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT banerjeearnob p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT chastainkatherine p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT peralespuchaltalfredo p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT stephensontara p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT uhlarclarissa p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT kobosrachel p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT veronaraluca p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients
AT vandedonknielswcj p1506teclistamabreducespolyclonalimmunoglobulinlevelsandimpairsvaccinationresponsesinheavilypretreatedmmpatients